Journal article
Gadolinium-153 as a brachytherapy isotope
Physics in medicine & biology, Vol.58(4), pp.957-964
01/23/2013
DOI: 10.1088/0031-9155/58/4/957
PMID: 23339848
Abstract
The purpose of this work was to present the fundamental dosimetric characteristics of a hypothetical 153Gd brachytherapy source using the AAPM TG-43U1 dose-calculation formalism. Gadolinium-153 is an intermediate-energy isotope that emits 40-100 keV photons with a half-life of 242 days. The rationale for considering 153Gd as a brachytherapy source is for its potential of patient specific shielding and to enable reduced personnel shielding requirements relative to 192Ir, and as an isotope for interstitial rotating shield brachytherapy (I-RSBT). A hypothetical 153Gd brachytherapy source with an active core of 0.84 mm diameter, 10 mm length and specific activity of 5.55 TBq of 153Gd per gram of Gd was simulated with Geant4. The encapsulation material was stainless steel with a thickness of 0.08 mm. The radial dose function, anisotropy function and photon spectrum in water were calculated for the 153Gd source. The simulated 153Gd source had an activity of 242 GBq and a dose rate in water 1 cm off axis of 13.12 Gy h−1, indicating that it would be suitable as a low-dose-rate or pulsed-dose-rate brachytherapy source. The beta particles emitted have low enough energies to be absorbed in the source encapsulation. Gadolinium-153 has an increasing radial dose function due to multiple scatter of low-energy photons. Scattered photon dose takes over with distance from the source and contributes to the majority of the absorbed dose. The anisotropy function of the 153Gd source decreases at low polar angles, as a result of the long active core. The source is less anisotropic at polar angles away from the longitudinal axes. The anisotropy function increases with increasing distance. The 153Gd source considered would be suitable as an intermediate-energy low-dose-rate or pulsed-dose-rate brachytherapy source. The source could provide a means for I-RSBT delivery and enable brachytherapy treatments with patient specific shielding and reduced personnel shielding requirements relative to 192Ir.
Details
- Title: Subtitle
- Gadolinium-153 as a brachytherapy isotope
- Creators
- Shirin A Enger - Uppsala University Section of Oncology, Department of Radiology, Oncology and Radiation Science, Uppsala, SwedenDarrell R Fisher - Pacific Northwest National Laboratory Isotope Sciences Program, 902 Battelle Blvd, Richland, WA 99352, USARyan T Flynn - University of Iowa Department of Radiation Oncology, 200 Hawkins Drive, Iowa City, IA 52242, USA
- Resource Type
- Journal article
- Publication Details
- Physics in medicine & biology, Vol.58(4), pp.957-964
- Publisher
- IOP Publishing
- DOI
- 10.1088/0031-9155/58/4/957
- PMID
- 23339848
- ISSN
- 0031-9155
- eISSN
- 1361-6560
- Language
- English
- Date published
- 01/23/2013
- Academic Unit
- Radiation Oncology
- Record Identifier
- 9984047705602771
Metrics
14 Record Views